Brain insulin, insulin‐like growth factor 1 and glucagon‐like peptide 1 signalling in Alzheimer's disease

ST Ferreira - Journal of Neuroendocrinology, 2021 - Wiley Online Library
Although the brain was once considered an insulin‐independent organ, insulin signalling is
now recognised as being central to neuronal health and to the function of synapses and …

Brain insulin, insulin‐like growth factor 1 and glucagon‐like peptide 1 signalling in Alzheimer's disease.

ST Ferreira - Journal of Neuroendocrinology, 2021 - search.ebscohost.com
Although the brain was once considered an insulin‐independent organ, insulin signalling is
now recognised as being central to neuronal health and to the function of synapses and …

Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease.

ST Ferreira - 2021 - cabidigitallibrary.org
Although the brain was once considered an insulin-independent organ, insulin signalling is
now recognised as being central to neuronal health and to the function of synapses and …

Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease

ST Ferreira - Journal of neuroendocrinology, 2021 - pubmed.ncbi.nlm.nih.gov
Although the brain was once considered an insulin-independent organ, insulin signalling is
now recognised as being central to neuronal health and to the function of synapses and …

Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease.

ST Ferreira - Journal of Neuroendocrinology, 2021 - europepmc.org
Although the brain was once considered an insulin-independent organ, insulin signalling is
now recognised as being central to neuronal health and to the function of synapses and …